A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug certolizumab significantly reduces the risk of serious adverse pregnancy outcomes ...

The tumor necrosis factor (TNF) inhibitor certolizumab pegol (Cimzia) appears to significantly increase the survival rate for pregnancies complicated by antiphospholipid syndrome (APS), an autoimmune ...

Please provide your email address to receive an email when new articles are posted on . For pregnancies at 20 weeks of gestation or greater, many IMIDs were “only weakly associated” with risk for ...

Credit: Getty Images More than 20% of ischemic strokes in patients aged 45 years or younger are associated with Antiphospholipid syndrome, but its exact etiology and pathophysiology are not yet fully ...

APS is a rare autoimmune disorder affecting up to 0.05% of people. It is frequently associated with lupus, a disease most prevalent in women during their reproductive years. In APS, the body produces ...